Next earnings date: 22 Oct 2025
Laurus Labs Limited – NSE:LAURUSLABS.NS
Laurus Labs Limited stock price today
Laurus Labs Limited stock price monthly change
Laurus Labs Limited stock price quarterly change
Laurus Labs Limited stock price yearly change
Laurus Labs Limited key metrics
Market Cap | 305.21B |
Enterprise value | 343.78B |
P/E | 239.96 |
EV/Sales | 6.80 |
EV/EBITDA | 43.71 |
Price/Sales | 6.25 |
Price/Book | 7.61 |
PEG ratio | -39.09 |
EPS | 2.97 |
Revenue | 50.40B |
EBITDA | 7.85B |
Income | 1.60B |
Revenue Q/Q | 4.25% |
Revenue Y/Y | -16.55% |
Profit margin | 2.59% |
Oper. margin | 7.14% |
Gross margin | 42.69% |
EBIT margin | 7.14% |
EBITDA margin | 15.58% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLaurus Labs Limited stock price history
Laurus Labs Limited stock forecast
Laurus Labs Limited financial statements
| Jun 2023 | 11.81B | 248.5M | 2.1% |
|---|---|---|---|
| Sep 2023 | 12.24B | 369.5M | 3.02% |
| Dec 2023 | 11.94B | 231.4M | 1.94% |
| Mar 2024 | 14.39B | 756.1M | 5.25% |
| 2026 | 68.28B | 7.23B | 10.59% |
|---|---|---|---|
| 2027 | 74.09B | 8.81B | 11.9% |
Analysts Price target
Financials & Ratios estimates
| 2024-10-24 | 0.91 | 0.37 |
|---|
| Payout ratio | 0% |
|---|
| 2016 | |
|---|---|
| 2017 | 0.11% |
| 2019 | 0.38% |
| 2020 | 1.11% |
| 2022 | 0.27% |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 80576300000 | 40.14B | 49.82% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 83870300000 | 42.71B | 50.93% |
| Jun 2023 | 1.81B | 0 | 0 |
|---|---|---|---|
| Sep 2023 | 1.86B | 0 | 0 |
| Dec 2023 | 1.96B | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 |
Laurus Labs Limited alternative data
| Aug 2023 | 5,753 |
|---|---|
| Sep 2023 | 5,753 |
| Oct 2023 | 5,753 |
| Nov 2023 | 5,753 |
| Dec 2023 | 5,753 |
| Jan 2024 | 5,753 |
| Feb 2024 | 5,753 |
| Mar 2024 | 5,753 |
| Apr 2024 | 5,753 |
| May 2024 | 5,753 |
| Jun 2024 | 5,753 |
| Jul 2024 | 6,007 |
Laurus Labs Limited other data
| Insider | Compensation |
|---|---|
Dr. Satyanarayana Chava M.Sc., Ph.D. (1961) Chief Executive Officer & Whole Time Director | $178,570,000 |
Mr. Vantaram Venkata Ravi Kumar F.C.M.A., DIS, Dip in Mgmt. (1965) Chief Financial Officer & Whole-Time Director | $43,980,000 |
-
What's the price of Laurus Labs Limited stock today?
One share of Laurus Labs Limited stock can currently be purchased for approximately $528.75.
-
When is Laurus Labs Limited's next earnings date?
Laurus Labs Limited is estimated to report earnings on Wednesday, 22 Oct 2025.
-
Does Laurus Labs Limited pay dividends?
Yes, Laurus Labs Limited pays dividends and its trailing 12-month yield is 0.14% with 0% payout ratio. The last Laurus Labs Limited stock dividend of $0 was paid on 11 Sep 2025.
-
How much money does Laurus Labs Limited make?
Laurus Labs Limited has a market capitalization of 305.21B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.32% to 50.02B US dollars. Laurus Labs Limited earned 1.61B US dollars in net income (profit) last year or $0.37 on an earnings per share basis.
-
What is Laurus Labs Limited's stock symbol?
Laurus Labs Limited is traded on the NSE under the ticker symbol "LAURUSLABS.NS".
-
What is Laurus Labs Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Laurus Labs Limited?
Shares of Laurus Labs Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Laurus Labs Limited's key executives?
Laurus Labs Limited's management team includes the following people:
- Dr. Satyanarayana Chava M.Sc., Ph.D. Chief Executive Officer & Whole Time Director(age: 64, pay: $178,570,000)
- Mr. Vantaram Venkata Ravi Kumar F.C.M.A., DIS, Dip in Mgmt. Chief Financial Officer & Whole-Time Director(age: 60, pay: $43,980,000)
-
How many employees does Laurus Labs Limited have?
As Jul 2024, Laurus Labs Limited employs 6,007 workers, which is 4% more then previous month and 4% more then previous quarter.
-
When Laurus Labs Limited went public?
Laurus Labs Limited is publicly traded company for more then 8 years since IPO on 19 Dec 2016.
-
What is Laurus Labs Limited's official website?
The official website for Laurus Labs Limited is lauruslabs.com.
-
How can i contact Laurus Labs Limited?
Laurus Labs Limited can be reached via phone at +91 40 3980 4333.
Laurus Labs Limited company profile:
Laurus Labs Limited
lauruslabs.comNSE
6,007
Drug Manufacturers - Specialty & Generic
Healthcare
Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. The company was incorporated in 2005 and is based in Hyderabad, India.
Hyderabad, 500034
:
ISIN: INE947Q01028
CUSIP: Y2090Y105
